- $2.12bn
- $3.15bn
- $758.74m
- 64
- 53
- 92
- 79
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 669 | 717 | 719 | 719 | 759 |
Cost of Revenue | |||||
Gross Profit | 471 | 505 | 492 | 623 | 672 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 589 | 665 | 752 | 1,539 | 608 |
Operating Profit | 79.9 | 52.3 | -32.9 | -820 | 150 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -28.2 | -24.1 | -96.9 | -908 | 34.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -25.1 | 116 | -64.5 | -929 | -9.11 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 18.6 | 158 | -51.4 | -929 | -9.11 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.4 | 158 | -51.6 | -929 | -9.11 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.112 | 0.827 | -0.087 | -2.05 | 0.027 |
Special Dividends per Share |